U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 114

1.
Irrespective of CD34 expression, lineage‐committed cell fraction reconstitutes and re‐establishes transformed Philadelphia chromosome‐positive leukemia in NOD / SCID / IL‐2Rγc−/− mice
Ryohei Tanizaki, Yuka Nomura, Yasuhiko Miyata, Yosuke Minami, Akihiro Abe, Akitoshi Hanamura, Masashi Sawa, Makoto Murata, Hitoshi Kiyoi, Tadashi Matsushita, Tomoki Naoe
Cancer Sci. 2010 Mar; 101(3): 631–638. Published online 2009 Nov 16. doi: 10.1111/j.1349-7006.2009.01440.x
PMCID:
PMC11159776
AbstractArticlePDF–1.0M
2.
Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells
Masayoshi Kobune, Rishu Takimoto, Kazuyuki Murase, Satoshi Iyama, Tsutomu Sato, Shohei Kikuchi, Yutaka Kawano, Kohji Miyanishi, Yasushi Sato, Yoshiro Niitsu, Junji Kato
Cancer Sci. 2009 May; 100(5): 948–955. Published online 2009 Feb 24. doi: 10.1111/j.1349-7006.2009.01111.x
PMCID:
PMC11158794
AbstractArticlePDF–2.5M
3.
Extracellular vesicle-derived TP53BP1, CD34, and PBX1 from human peripheral blood serve as potential biomarkers for the assessment and prediction of vascular aging
Yichao Wen, Haiyang Chen, Yu Wang, Yiqing Sun, Fangfang Dou, Xiling Du, Te Liu, Chuan Chen
Hereditas. 2024; 161: 3. Published online 2024 Jan 3. doi: 10.1186/s41065-023-00306-8
PMCID:
PMC10763334
AbstractArticlePDF–7.1M
4.
Expression of Markers Ki-67, Nestin, VEGF, CD34 and Apoptosis in Relatively Healthy Lung Tissue with Non-Changed and Metaplastic Bronchial Epithelium
Kaiva Zile Zarina, Mara Pilmane
Med Sci (Basel) 2023 Mar; 11(1): 7. Published online 2022 Dec 29. doi: 10.3390/medsci11010007
PMCID:
PMC9844367
AbstractArticlePDF–4.5M
5.
Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice
Noriyuki Saito, Takuji Yamauchi, Noriaki Kawano, Rintaro Ono, Shuro Yoshida, Toshihiro Miyamoto, Tomohiko Kamimura, Leonard D. Shultz, Yoriko Saito, Katsuto Takenaka, Kazuya Shimoda, Mine Harada, Koichi Akashi, Fumihiko Ishikawa
Int J Hematol. Author manuscript; available in PMC 2022 Mar 9.
Published in final edited form as: Int J Hematol. 2022 Feb; 115(2): 198–207. Published online 2021 Nov 13. doi: 10.1007/s12185-021-03239-y
PMCID:
PMC8905546
AbstractArticlePDF–1.2M
6.
Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells
Julian Baumeister, Tiago Maié, Nicolas Chatain, Lin Gan, Barbora Weinbergerova, Marcelo A. S. de Toledo, Jörg Eschweiler, Angela Maurer, Jiri Mayer, Blanka Kubesova, Zdenek Racil, Andreas Schuppert, Ivan Costa, Steffen Koschmieder, Tim H. Brümmendorf, Deniz Gezer
Ann Hematol. 2021; 100(12): 2943–2956. Published online 2021 Aug 14. doi: 10.1007/s00277-021-04615-8
PMCID:
PMC8592960
AbstractArticlePDF–2.1M
7.
Significance of hematopoietic surface antigen CD34 in neuroblastoma prognosis and the genetic landscape of CD34-expressing neuroblastoma CSCs
Natarajan Aravindan, Dincsh Babu Somasundaram, Terence S. Herman, Sheeja Aravindan
Cell Biol Toxicol. Author manuscript; available in PMC 2022 Jun 1.
Published in final edited form as: Cell Biol Toxicol. 2021 Jun; 37(3): 461–478. Published online 2020 Sep 26. doi: 10.1007/s10565-020-09557-x
PMCID:
PMC8529858
AbstractArticlePDF–1.7M
8.
Prognostic value of CD34 expression status in patients with myxofibrosarcomas and undifferentiated pleomorphic sarcomas
Yoshiya Sugiura, Rikuo Machinami, Seiichi Matsumoto, Hiroaki Kanda, Keisuke Ae, Yutaka Takazawa, Kengo Takeuchi
Sci Rep. 2021; 11: 15494. Published online 2021 Jul 29. doi: 10.1038/s41598-021-94834-w
PMCID:
PMC8322140
AbstractArticlePDF–1.8M
9.
CD34 is not Expressed by Blasts in a Third of B-ALL Patients and Its Negativity is associated with Aberrant Marker Expression: A Retrospective Analysis
Neha Garg, Richa Gupta, Mrinalini Kotru
Asian Pac J Cancer Prev. 2021 Mar; 22(3): 919–925. doi: 10.31557/APJCP.2021.22.3.919
PMCID:
PMC8286681
AbstractArticlePDF–394K
10.
CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer
Yun Lin, Zhi Li, Mubiao Liu, Haiyan Ye, Jianhui He, Jianguo Chen
Arch Gynecol Obstet. 2021; 304(2): 495–501. Published online 2021 Jan 3. doi: 10.1007/s00404-020-05921-8
PMCID:
PMC8277608
AbstractArticlePDF–1.0M
11.
microRNA Sequencing of CD34+ Sorted Adipose Stem Cells Undergoing Endotheliogenesis
Shahensha Shaik, Elizabeth Martin, Daniel Hayes, Jeffrey Gimble, Ram Devireddy
Stem Cells Dev. March 1, 2021; 30(5): 265–288. Published online 2021 Mar 3. doi: 10.1089/scd.2020.0173
PMCID:
PMC7994430
AbstractArticlePDF–2.2M
12.
Prognostic relevance of the loss of stromal CD34 positive fibroblasts in invasive lobular carcinoma of the breast
Christina C. Westhoff, Paul Jank, Christian O. Jacke, Ute-Susann Albert, Schokufe Ebrahimsade, Peter J. Barth, Roland Moll
Virchows Arch. 2020; 477(5): 717–724. Published online 2020 May 20. doi: 10.1007/s00428-020-02835-3
PMCID:
PMC7581514
AbstractArticlePDF–964K
13.
Correlation between peripheral blood neutrophil-lymphocyte ratio and CD34 expression in prostate cancer
Yiyang Wang, Xiaofei Dong, Zhaokui Qu, Kang Peng, Xiaolei Sun, Renfu Chen
BMC Cancer. 2020; 20: 900. Published online 2020 Sep 22. doi: 10.1186/s12885-020-07382-3
PMCID:
PMC7510314
AbstractArticlePDF–1.5M
14.
Angiogenic Factors Are Increased in Circulating Granulocytes and CD34+ Cells of Myeloproliferative Neoplasms
Tijana Subotički, Olivera Mitrović Ajtić, Bojana B. Beleslin-Čokić, Ronny Nienhold, Miloš Diklić, Dragoslava Djikić, Danijela Leković, Tanja Bulat, Dragana Marković, Mirjana Gotić, Constance T. Noguchi, Alan N. Schechter, Radek C. Skoda, Vladan P. Čokić
Mol Carcinog. Author manuscript; available in PMC 2020 Jun 10.
Published in final edited form as: Mol Carcinog. 2017 Feb; 56(2): 567–579. Published online 2016 Jul 8. doi: 10.1002/mc.22517
PMCID:
PMC7286093
AbstractArticlePDF–1.6M
15.
Diagnostic importance of clinicopathologic features and p16, CD34, MDM2 expression in differential diagnosis of adipocytic tumors
Eren Altun, Seher Yüksel, Gülşah Kaygusuz, Hüseyin Yusuf Yıldız
Acta Orthop Traumatol Turc. 2020 Jan; 54(1): 59–65. doi: 10.5152/j.aott.2020.01.445
PMCID:
PMC7243699
AbstractArticlePDF–3.6M
16.
The effect of smoking on clinical presentation and expression of TLR-2 and CD34 in Oral lichen Planus patients: clinical and immunohistochemical study
Nermine Raouf Amin, Nermin Yussif, Enji Ahmed
BMC Oral Health. 2020; 20: 129. Published online 2020 Apr 29. doi: 10.1186/s12903-020-01118-2
PMCID:
PMC7191681
AbstractArticlePDF–4.8M
17.
A reference map of the human binary protein interactome
Katja Luck, Dae-Kyum Kim, Luke Lambourne, Kerstin Spirohn, Bridget E. Begg, Wenting Bian, Ruth Brignall, Tiziana Cafarelli, Francisco J. Campos-Laborie, Benoit Charloteaux, Dongsic Choi, Atina G. Coté, Meaghan Daley, Steven Deimling, Alice Desbuleux, Amélie Dricot, Marinella Gebbia, Madeleine F. Hardy, Nishka Kishore, Jennifer J. Knapp, István A. Kovács, Irma Lemmens, Miles W. Mee, Joseph C. Mellor, Carl Pollis, Carles Pons, Aaron D. Richardson, Sadie Schlabach, Bridget Teeking, Anupama Yadav, Mariana Babor, Dawit Balcha, Omer Basha, Christian Bowman-Colin, Suet-Feung Chin, Soon Gang Choi, Claudia Colabella, Georges Coppin, Cassandra D’Amata, David De Ridder, Steffi De Rouck, Miquel Duran-Frigola, Hanane Ennajdaoui, Florian Goebels, Liana Goehring, Anjali Gopal, Ghazal Haddad, Elodie Hatchi, Mohamed Helmy, Yves Jacob, Yoseph Kassa, Serena Landini, Roujia Li, Natascha van Lieshout, Andrew MacWilliams, Dylan Markey, Joseph N. Paulson, Sudharshan Rangarajan, John Rasla, Ashyad Rayhan, Thomas Rolland, Adriana San-Miguel, Yun Shen, Dayag Sheykhkarimli, Gloria M. Sheynkman, Eyal Simonovsky, Murat Taşan, Alexander Tejeda, Vincent Tropepe, Jean-Claude Twizere, Yang Wang, Robert J. Weatheritt, Jochen Weile, Yu Xia, Xinping Yang, Esti Yeger-Lotem, Quan Zhong, Patrick Aloy, Gary D. Bader, Javier De Las Rivas, Suzanne Gaudet, Tong Hao, Janusz Rak, Jan Tavernier, David E. Hill, Marc Vidal, Frederick P. Roth, Michael A. Calderwood
Nature. Author manuscript; available in PMC 2020 Oct 8.
Published in final edited form as: Nature. 2020 Apr; 580(7803): 402–408. Published online 2020 Apr 8. doi: 10.1038/s41586-020-2188-x
PMCID:
PMC7169983
AbstractArticlePDF–5.4M
18.
Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB/c nude mice model
Seon-Jin Yoon, Jungmin Park, Youngmin Shin, Yuna Choi, Sahng Wook Park, Seok-Gu Kang, Hye Young Son, Yong-Min Huh
BMC Cancer. 2020; 20: 314. Published online 2020 Apr 15. doi: 10.1186/s12885-020-06814-4
PMCID:
PMC7160933
AbstractArticlePDF–3.9M
19.
Prognostic impact of CD34 and SMA in cancer‐associated fibroblasts in stage I–III NSCLC
Arik Bernard Schulze, Lars Henning Schmidt, Birthe Heitkötter, Sebastian Huss, Michael Mohr, Alessandro Marra, Ludger Hillejan, Dennis Görlich, Peter J. Barth, Jan Rehkämper, Georg Evers
Thorac Cancer. 2020 Jan; 11(1): 120–129. Published online 2019 Nov 24. doi: 10.1111/1759-7714.13248
PMCID:
PMC6938745
AbstractArticlePDF–968K
20.
CD34 Identifies a Subset of Proliferating Microglial Cells Associated with Degenerating Motor Neurons in ALS
Mariángeles Kovacs, Emiliano Trias, Valentina Varela, Sofia Ibarburu, Joseph S. Beckman, Ivan C. Moura, Olivier Hermine, Peter H. King, Ying Si, Yuri Kwon, Luis Barbeito
Int J Mol Sci. 2019 Aug; 20(16): 3880. Published online 2019 Aug 9. doi: 10.3390/ijms20163880
PMCID:
PMC6720880
AbstractArticlePDF–2.9M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center